US 12285424
Methods for treating neutropenia
granted A61KA61K31/4709A61K38/193
Quick answer
US patent 12285424 (Methods for treating neutropenia) held by X4 Pharmaceuticals, Inc. expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- X4 Pharmaceuticals, Inc.
- Grant date
- Tue Apr 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/4709, A61K38/193, A61K9/0019, A61P